Full Paper
[Ru-14]: (62 % method I, 44 % method II). 1H NMR (400 MHz,
CD2Cl2): δ = 16.81 (s, 1 H), 8.68 (d, J = 5.2 Hz, 1 H), 8.35 (t, J =
7.8 Hz, 1 H), 7.92–7.81 (m, 1 H), 7.77 (d, J = 8.0 Hz, 1 H), 7.55 (d, J =
5.2 Hz, 1 H), 7.41 (t, J = 7.6 Hz, 1 H), 7.25 (s, 2 H), 7.09–6.99 (m, 3
H), 6.80 (d, J = 6.6 Hz, 4 H), 6.66 (d, J = 8.3 Hz, 1 H), 6.46 (t, J =
7.2 Hz, 1 H), 4.22–3.89 (m, 4 H), 2.74 (s, 6 H), 2.42 (s, 6 H), 2.27 (s, 3
H), 1.94 (s, 6 H) ppm. 13C NMR (101 MHz, CD2Cl2): δ = 309.6, 214.7,
153.1, 150.8, 141.1, 140.3, 138.8, 138.3, 137.7, 136.4, 135.7, 131.0,
129.9, 129.7, 128.6, 128.3, 127.8, 126.7, 124.1, 121.8, 117.0, 116.2,
methylsilyl chloride or HCl they can be used as very active cata-
lysts for numerous metathesis reactions, such as RCM, enyne
cycloisomerisation and CM, also with more functionalised sub-
strates such as S3, S4 and S6a. Moreover, due to their latency
and possibility of on-demand activation, the Ru amide com-
plexes can be used in ROMP of DCPD (S8) and endo,exo-
bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid (S9). Although
the best catalysts ([Ru-12], [Ru-18] and [Ru-20]) produced
poly-DCPD that showed reasonable results in mechanical tests,
52.0, 20.9, 19.1, 18.0 ppm. IR (film CH2Cl2): ν = 2955, 2912, 1600,
˜
the low solubility of the new complexes in non-polar solvents 1583, 1458, 1447, 1314, 1259, 1152, 1020, 957, 853, 826, 751, 655,
565 cm–1. HRMS (ESI, m/z) [M – Cl]+ calcd. 745.2150, found 745.2159.
could restrict their commercial applications, as compared to the
fully soluble LatMet catalyst family.[8]
[Ru-16]: (88 % method I, 53 % method II). 1H NMR (400 MHz,
CD2Cl2): δ = 17.23 (s, 1 H), 8.48 (d, J = 20.8, Hz, 1 H), 7.66–7.63 (m,
1 H), 7.62–7.53 (m, 2 H), 7.46–7.37 (m, 2 H), 7.44–7.38 (m, 1 H), 7.28
(d, J = 7.5 Hz, 2 H), 6.87–6.80 (m, 1 H), 6.78–6.67 (m, 5 H), 4.42–4.19
(m, 2 H), 4.19–4.02 (m, 2 H), 3.95–3.75 (m, 2 H), 3.40–3.03 (m, 2 H),
Experimental Section
General Procedure for Synthesis of Complexes (Method I): A
Schlenk flask equipped with a magnetic stirring bar was charged
under argon with complex [Ru-3] (0.13 mmol), the first portion of
ligand (3a–3c) (0.13 mmol), anhydrous toluene (7 mL) and anhy-
1.44 (d, J = 14.6 Hz, 6 H), 1.36–1.26 (m, 6 H), 1.22–1.11 (m, 6 H),
0.65–0.25 (m, 6 H) ppm. 13C NMR (101 MHz, CD2Cl2): δ = 312.1,
311.7, 215.6, 151.9, 151.1, 148.9, 137.1, 136.7, 131.0, 129.7, 124.9,
124.6, 123.5, 122.4, 121.2, 119.6, 31.9, 28.7, 28.2, 26.9, 26.2, 22.7,
drous pyridine/DMAP/3-bromopyridine (0.27 mmol). The reaction
22.4, 13.9 ppm. IR (film CH2Cl2): ν = 3284, 3063, 2965, 2928, 2869,
˜
mixture was stirred for 15 min at 70 °C. Than the second portion of
1932, 1726, 1618, 1578, 1539, 1461, 14057, 1326, 1267, 1237, 1160,
3a–3c (0.13 mmol) was added and the reaction was allowed to
1048, 932, 760, 724, 694, 550, 458 cm–1. MS (FD, m/z): 806.2 [M]+.
proceed for 15 min. After this time the resulting mixture was puri-
1
fied by column chromatography with 10–30 % hexane/ethyl acet-
[Ru-18]: (70 % method II). H NMR (400 MHz, CD2Cl2): δ = 17.12 (s,
ate. After evaporation of solvents, the resulting solid was collected,
dissolved in CH2Cl2 and washed a few times with n-pentane to give
the pure product.
1 H), 8.45 (d, J = 8.3 Hz, 1 H), 7.48–7.37 (m, 2 H), 7.31 (s, 2 H), 7.26
(dd, J = 6.6, 1.4 Hz, 2 H), 6.95 (s, 2 H), 6.93–6.89 (m, 1 H), 6.88–6.75
(m, 3 H), 2.51 (s, 6 H), 2.33 (s, 6 H), 1.85 (s, 6 H), 1.58 (s, 6 H) ppm.
13C NMR (101 MHz, CD2Cl2): δ = ppm: 314.0, 177.6, 161.9, 161.6,
153.5, 151.8, 148.9, 139.7, 138.0, 137.5, 136.2, 134.4, 130.4, 129.5,
127.2, 124.6, 123.5, 122.7, 120.9, 20.9, 18.6, 17.6, 8.8 ppm. IR (film
General Procedure for Synthesis of Complexes (Method II): A
Schlenk flask equipped with a magnetic stirring bar was charged
under argon with complex [Ru-1] (0.053 mmol), ligand (3a–3c)
(0.116 mmol), tricyclohexylphosphane (0.159 mmol) and anhydrous
toluene (4 mL). The reaction mixture was stirred for 15 min at 70 °C.
Then anhydrous pyridine/DMAP/3-bromopyridine (0.27 mmol) was
added and the reaction mixture was heated for a further 15 min.
The resulting mixture was purified by column chromatography with
10–30 % hexane/ethyl acetate. After evaporation of solvents, the
resulting solid was collected, dissolved in CH2Cl2 and washed a few
times with n-pentane to give the pure product.
CH2Cl2): ν = 3654, 3441, 2922, 1609, 1564, 1484, 1462, 1359, 1291,
˜
1235, 1144, 1133, 1034, 942, 857, 757, 701, 589 cm–1. HRMS (ESI,
m/z) [M + Na]+ calcd. 771.1627; found 771.1611.
[Ru-19]: (62 % method I, 38 % method II). 1H NMR (400 MHz,
CDCl3): δ = 16.92 (s, 1 H), 8.55 (d, J = 8.4 Hz, 1 H), 7.63–7.48 (m, 1
H), 7.39 (s, 1 H), 7.29–7.21 (m, 3 H), 7.10 (d, J = 5.6 Hz, 1 H), 6.92 (s,
2 H), 6.77 (d, J = 4.0 Hz, 2 H), 6.65–6.48 (m, 1 H), 4.30–3.68 (m, 4 H),
2.60 (s, 6 H), 2.45 (s, 6 H), 1.90 (s, 6 H) ppm. 13C NMR (101 MHz,
CDCl3): δ = 213.6, 153.4, 152.4, 150.7, 149.2, 139.2, 138.9, 138.3,
132.0, 129.9, 124.8, 124.1, 122.6, 121.4, 120.5, 51.9, 21.2, 18.9,
[Ru-12]: (85 % method I, 54 % method II). 1H NMR (400 MHz,
CD2Cl2): δ = 17.46 (s, 1 H), 8.67 (d, J = 4 Hz, 1 H), 7.51 (m, 2 H),
7.40–7.14 (m, 2 H), 7.01–6.97 (m, 4 H), 6.9 (t, J = 7.4 Hz, 1 H), 6.63
(dd, J = 7.4, 1.4 Hz, 1 H), 4.14–3.35 (m, 4 H), 2.82, 2.56, 2.43, 2.32,
2.16 (br. s, 18 H) ppm. 13C NMR (101 MHz, CD2Cl2): δ = 301.4, 218.6,
150.4, 150.1, 137.5, 137.3, 131.5, 130.9, 130.1, 129.2, 128.2, 128.0,
127.9, 127.4, 126.6, 126.3, 125.7, 124.9, 123.7, 122.5, 122.5, 121.3,
18.0 ppm. IR (film CH2Cl2): ν = 2912, 1721, 1628, 1577, 1480, 1447,
˜
1266, 1228, 1160, 1123, 1041, 760, 732, 696, 576 cm–1. HRMS (ESI,
m/z) [M – Cl]+ calcd. 765.0990; found 765.0988.
1
[Ru-20]: (80 % method I). H NMR (400 MHz, CD2Cl2): δ = 17.06 (s,
1 H), 8.42 (d, J = 8.3 Hz, 1 H), 7.37 (m, 1 H), 7.21 (s, 2 H), 6.91 (s, 2
H), 6.81 (s, 2 H), 6.74–6.47 (m, 2 H), 6.03 (d, J = 7.4 Hz, 2 H), 4.06 (s,
4 H), 2.89–2.44 (m, 18 H), 1.94 (s, 6 H) ppm. 13C NMR (101 MHz,
CD2Cl2): δ = 214.9, 157.8, 153.5, 151.2, 148.5, 138.7, 138.4, 130.1,
129.7, 123.4, 122.4, 120.8, 107.1, 51.8, 38.8, 20.8, 18.8, 17.8 ppm. IR
51.6, 35.2, 29.6, 22.3, 20.7, 18.4, 13.8 ppm. IR (film CH2Cl2): ν = 3284,
˜
3024, 2918, 2858, 1942, 1727, 1621, 1578, 1537, 1485, 1458, 1448,
1417, 1282, 1266, 1240, 1231, 1204, 1160, 1034, 930, 852, 761, 724,
695, 578, 423 cm–1. MS (ESI, m/z) [M – Cl]+: 687.2. Complex [Ru-12]
was described previously.[10]
(film CH2Cl2): ν = 3325, 2911, 1621, 1562, 1541, 1394, 1229, 1146,
˜
[Ru-13]: (72 % method I, 47 % method II). 1H NMR (400 MHz,
CD2Cl2): δ = 16.80 (s, 1 H), 8.17 (d, J = 8.5 Hz, 1 H), 7.42 (d, J =
4.9 Hz, 3 H), 7.38–7.28 (m, 1 H), 7.03 (s, 3 H), 6.95–6.89 (m, 2 H),
1032, 806, 578, 515 cm–1. HRMS (ESI, m/z) [M – Cl]+ calcd. 730.2307;
found 730.2309.
6.59 (t, J = 7.2 Hz, 2 H), 6.49 (dd, J = 7.6, 1.4 Hz, 1 H), 3.73 (s, 4 H), Representative Procedure for Catalytic Test RCM of Substrate
2.38–1.52 (m, 18 H), 0.97 (s, 9 H) ppm. 13C NMR (101 MHz, CD2Cl2):
δ = 221.1, 195.1, 160.9, 158.2, 150.2, 149.2, 136.1, 135.8, 129.9, 129.5,
129.0, 128.8, 123.3, 121.4, 119.6, 117.9, 117.0, 77.5, 51.3, 28.6, 27.9,
S1: Comparative RCM experiments with substrate S1 (CH2Cl2, c =
0.1 , 40 °C) were performed as follows. The catalyst (1 mol-%,
500 ppm or 50 ppm) and an ethereal solution of HCl (0.0399 mmol,
M
27.7, 20.8 ppm. IR (film CH2Cl2): ν = 3356, 2916, 1699, 1604, 1584, 10 mol-%) were added in a single portion to a stirred solution of
˜
1518, 1482, 1445, 1263, 1153, 1043, 757, 694, 577 cm–1. HRMS (ESI, S1 (100 mg, 0.399 mmol) and durene (internal standard, 54 mg,
m/z) [M – Cl]+ calcd. 691.2586, found 691.2599.
0.399 mmol) in CH2Cl2 (4 mL) under argon in a Schlenk tube at
Eur. J. Inorg. Chem. 2018, 1766–1774
1772 © 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim